Comparison and validation of genomic predictors for anticancer drug sensitivity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison and validation of genomic predictors for anticancer drug sensitivity
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
Volume 20, Issue 4, Pages 597-602
Publisher
Oxford University Press (OUP)
Online
2013-01-27
DOI
10.1136/amiajnl-2012-001442
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer
- (2012) Fei-Yun Yang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis
- (2012) Rui Ding et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Role of NQO1 609C>T and NQO2 −3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis
- (2012) Manzoor Ahmad Malik et al. MOLECULAR BIOLOGY REPORTS
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Jetset: selecting the optimal microarray probe set to represent a gene
- (2011) Qiyuan Li et al. BMC BIOINFORMATICS
- Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines
- (2011) Lawson Eng et al. BMC Medical Genomics
- Heat Shock Proteins: A Potential Anticancer Target
- (2011) Kamalesh K. Sankhala et al. CURRENT DRUG TARGETS
- Mapping the interaction of Snf1 with TORC1 in Saccharomyces cerevisiae
- (2011) J. Zhang et al. Molecular Systems Biology
- Advances in the preclinical testing of cancer therapeutic hypotheses
- (2011) Giordano Caponigro et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- Frozen robust multiarray analysis (fRMA)
- (2010) M. N. McCall et al. BIOSTATISTICS
- Clinical Implications of the Cancer Genome
- (2010) Laura E. MacConaill et al. JOURNAL OF CLINICAL ONCOLOGY
- CellMiner: a relational database and query tool for the NCI-60 cancer cell lines
- (2009) Uma T Shankavaram et al. BMC GENOMICS
- Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
- (2009) Ultan McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway
- (2009) Kwong-Kwok Wong Recent Patents on Anti-Cancer Drug Discovery
- Integrated analysis of breast cancer cell lines reveals unique signaling pathways
- (2009) Laura M Heiser et al. GENOME BIOLOGY
- A study of pre-validation
- (2008) Holger Höfling et al. Annals of Applied Statistics
- A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
- (2008) B. Haibe-Kains et al. BIOINFORMATICS
- Mouse xenograft models vs GEM models for human cancer therapeutics
- (2008) A. Richmond et al. Disease Models & Mechanisms
- A modular approach for integrative analysis of large-scale gene-expression and drug-response data
- (2008) Zoltán Kutalik et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started